{"content":"<li class=\"n-box-item date-title\" data-end=\"1531540799\" data-start=\"1531454400\" data-txt=\"Monday, December 23, 2019\">Friday, July 13, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3370106\" data-ts=\"1531517961\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEW\" target=\"_blank\">NEW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370106-after-hours-gainers-losers-07-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (07/13/2018)</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/NEW' title='Puxin'>NEW</a> <font color='green'>+2.0%</font>. <a href='https://seekingalpha.com/symbol/VIRT' title='Virtu Financial, Inc.'>VIRT</a> <font color='green'>+1.9%</font>. <a href='https://seekingalpha.com/symbol/XOG' title='Extraction Oil & Gas'>XOG</a> <font color='green'>+1.7%</font>. <a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a> <font color='green'>+1.5%</font>. <a href='https://seekingalpha.com/symbol/DNR' title='Denbury Resources Inc.'>DNR</a> <font color='green'>+1.4%</font>.</li><li><b>Top Losers:</b>&nbsp;<a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a>&nbsp;<font color='red'>-3.3%</font>. <a href='https://seekingalpha.com/symbol/AAOI' title='Applied Optoelectronics, Inc.'>AAOI</a>&nbsp;<font color='red'>-2.3%</font>. <a href='https://seekingalpha.com/symbol/ITUB' title='Itau Unibanco Holding S.A.'>ITUB</a> <font color='red'>-1.5%</font>. <a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a> <font color='red'>-1.4%</font>. <a href='https://seekingalpha.com/symbol/CRK' title='Comstock Resources Inc.'>CRK</a> <font color='red'>-1.2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3370106\" data-linked=\"After Hours Gainers / Losers (07/13/2018)\" data-tweet=\"$NEW $NEW $VIRT - After Hours Gainers / Losers (07/13/2018) https://seekingalpha.com/news/3370106-after-hours-gainers-losers-07-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3370106-after-hours-gainers-losers-07-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370105\" data-ts=\"1531517803\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370105-netflix-slips-deutsche-bank-sounds-subscriber-caution\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix slips as Deutsche Bank sounds subscriber caution</a></h4><ul>   <li>Netflix (<a href=\"http://seekingalpha.com/symbol/NFLX\" target=\"_blank\">NFLX</a> <font color='red'>-4.3%</font>) ended up with its worst day in weeks after Deutsche Bank sounded some cautions ahead of Monday's afternoon earnings release.</li>    <li>There's near-term downside risk in the current subscriber numbers, says analyst Bryan Kraft, who's expecting a meet at best or a miss on global net adds. The stock's also doubled in 2018, which means it will take a meaningful boost to forecasts to spur a move up in coming days. (h/t Bloomberg)</li>    <li>Kraft still rates the stock a Buy.</li>    <li>Analyst consensus is for the company to post EPS of $0.79 (net income of $357.2M) on revenues of $3.94B.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3370105\" data-linked=\"Netflix slips as Deutsche Bank sounds subscriber caution\" data-tweet=\"$NFLX - Netflix slips as Deutsche Bank sounds subscriber caution https://seekingalpha.com/news/3370105-netflix-slips-deutsche-bank-sounds-subscriber-caution?source=tweet\" data-url=\"https://seekingalpha.com/news/3370105-netflix-slips-deutsche-bank-sounds-subscriber-caution\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370075\" data-ts=\"1531513305\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVRO\" target=\"_blank\">NVRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370075-nevro-up-1-after-hours-ahead-of-business-update-and-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nevro up 1% after hours ahead of business update and Q2 results</a></h4><ul><li>Nevro (NYSE:<a href='https://seekingalpha.com/symbol/NVRO' title='Nevro'>NVRO</a>) will host a <a href=\"https://seekingalpha.com/pr/17215824-nevro-announce-preliminary-second-quarter-worldwide-revenue-discuss-full-year-2018-revenue\" target=\"_blank\">conference call</a> on Monday, July 16, at 8:30 am ET to discuss preliminary Q2 results and a business update.</li><li>Shares are up&nbsp;<font color='green'>1%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3370075\" data-linked=\"Nevro up 1% after hours ahead of business update and Q2 results\" data-tweet=\"$NVRO - Nevro up 1% after hours ahead of business update and Q2 results https://seekingalpha.com/news/3370075-nevro-up-1-after-hours-ahead-of-business-update-and-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3370075-nevro-up-1-after-hours-ahead-of-business-update-and-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370065\" data-ts=\"1531512671\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLRB\" target=\"_blank\">CLRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370065-cellectar-bio-to-reverse-split-shares-1-10-shares-up-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellectar Bio to reverse split shares 1:10; shares up 1% after hours</a></h4><ul><li>Cellectar Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a>) will execute a <a href=\"https://seekingalpha.com/pr/17215805-cellectar-announces-1minus-10-reverse-stock-split\" target=\"_blank\">1:10 reverse split</a> of its common stock effective after the close on Monday, July 16. Post-split trading will commence on Tuesday, July 17.</li><li>Shares are up&nbsp;<font color='green'>1%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3370065\" data-linked=\"Cellectar Bio to reverse split shares 1:10; shares up 1% after hours\" data-tweet=\"$CLRB - Cellectar Bio to reverse split shares 1:10; shares up 1% after hours https://seekingalpha.com/news/3370065-cellectar-bio-to-reverse-split-shares-1-10-shares-up-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3370065-cellectar-bio-to-reverse-split-shares-1-10-shares-up-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370064\" data-ts=\"1531512665\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PIXY\" target=\"_blank\">PIXY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370064-shiftpixy-reports-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ShiftPixy reports Q3 results</a></h4><ul><li>ShiftPixy (NASDAQ:<a href='https://seekingalpha.com/symbol/PIXY' title='ShiftPixy'>PIXY</a>): Q3 EPS of -$0.06</li><li>Revenue of $9.38M (+102.6% Y/Y)</li><li>Shares <font color='green'>+3.9%</font>.</li><li><a href='https://seekingalpha.com/pr/17215808-shiftpixy-inc-reports-fiscal-2018-third-quarter-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3370064\" data-linked=\"ShiftPixy reports Q3 results\" data-tweet=\"$PIXY - ShiftPixy reports Q3 results https://seekingalpha.com/news/3370064-shiftpixy-reports-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3370064-shiftpixy-reports-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370059\" data-ts=\"1531510840\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370059-facebook-twitter-google-to-return-to-capitol-on-tuesday-updated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook, Twitter, Google to return to Capitol on Tuesday (updated)</a></h4><ul>   <li>The House Judiciary Committee on Tuesday will hear from Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color='green'>+0.3%</font>), YouTube (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='green'>+0.5%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color='green'>+0.3%</font>) and Twitter (<a href=\"http://seekingalpha.com/symbol/TWTR\" target=\"_blank\">TWTR</a> <font color='red'>-1.6%</font>) on the issue of <a href=\"https://judiciary.house.gov/hearing/facebook-google-and-twitter-examining-the-content-filtering-practices-of-social-media-giants/\" target=\"_blank\">filtering content for political reasons</a>.</li>    <li>That follows criticism from conservative Republicans over what they say are politically motivated judgments involved in content removal.</li>    <li>The panel is likely to hear from technical expert representatives of the companies to explain their moderation approaches.</li><li><strong>Updated 4:05 p.m.:</strong>&nbsp;Twitter is sending Nick Pickles, who leads public policy strategy, Bloomberg reports.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3370059\" data-linked=\"Facebook, Twitter, Google to return to Capitol on Tuesday (updated)\" data-tweet=\"$GOOG $GOOG $GOOGL - Facebook, Twitter, Google to return to Capitol on Tuesday (updated) https://seekingalpha.com/news/3370059-facebook-twitter-google-to-return-to-capitol-on-tuesday-updated?source=tweet\" data-url=\"https://seekingalpha.com/news/3370059-facebook-twitter-google-to-return-to-capitol-on-tuesday-updated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370055\" data-ts=\"1531509715\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKRX\" target=\"_blank\">AKRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370055-akorn-down-8-fresenius-trial-winds-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akorn down 8% as Fresenius trial winds up</a></h4><ul><li>Akorn (<a href='https://seekingalpha.com/symbol/AKRX' title='Akorn, Inc.'>AKRX</a> <font color='red'>-8%</font>) slips on almost double normal volume. Today is the last day of its trial with Fresenius Medical Care (<a href='https://seekingalpha.com/symbol/FMS' title='Fresenius Medical Care AG & Co. KGAA'>FMS</a> <font color='green'>+0.2%</font>) regarding the latter's exit from their proposed $4.75B merger.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3347441-akorn-takes-issue-fresenius-planned-exit-merger-shares-34-percent-premarket\" target=\"_blank\">Akorn takes issue with Fresenius' planned exit from merger; shares down 34% premarket</a> (April 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3370055\" data-linked=\"Akorn down 8% as Fresenius trial winds up\" data-tweet=\"$AKRX $AKRX $FMS - Akorn down 8% as Fresenius trial winds up https://seekingalpha.com/news/3370055-akorn-down-8-fresenius-trial-winds-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3370055-akorn-down-8-fresenius-trial-winds-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370054\" data-ts=\"1531509679\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNPR\" target=\"_blank\">JNPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370054-rbc-cisco-arista-can-compete-amazon-gets-switches\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RBC: Cisco, Arista can compete if Amazon gets into switches</a></h4><ul>   <li>An <a href=\"https://seekingalpha.com/news/3370027-amazon-anxiety-network-switches-sector\" target=\"_blank\">entry into networking switches</a> by Amazon Web Services (<a href=\"http://seekingalpha.com/symbol/AMZN\" target=\"_blank\">AMZN</a> <font color='green'>+0.6%</font>) is a \"notable negative\" for rivals in the sector, but Cisco Systems (<a href=\"http://seekingalpha.com/symbol/CSCO\" target=\"_blank\">CSCO</a> <font color='red'>-4.2%</font>) and Arista Networks (<a href=\"http://seekingalpha.com/symbol/ANET\" target=\"_blank\">ANET</a> <font color='red'>-3.9%</font>) are probably OK just the same, RBC says.</li>    <li>Sales and revenue trends for the two are likely safe, analyst Mitch Steves says, as they have \"solid\" software products and switching revenue has been trending positive. (h/t Bloomberg)</li>    <li>He has Outperform ratings on both stocks. Juniper Networks (NYSE:<a href='https://seekingalpha.com/symbol/JNPR' title='Juniper Networks'>JNPR</a>), which RBC has at Sector Perform, is <font color='red'>2.5% lower</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3370054\" data-linked=\"RBC: Cisco, Arista can compete if Amazon gets into switches\" data-tweet=\"$JNPR $JNPR $AMZN - RBC: Cisco, Arista can compete if Amazon gets into switches https://seekingalpha.com/news/3370054-rbc-cisco-arista-can-compete-amazon-gets-switches?source=tweet\" data-url=\"https://seekingalpha.com/news/3370054-rbc-cisco-arista-can-compete-amazon-gets-switches\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370052\" data-ts=\"1531509169\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIGA\" target=\"_blank\">SIGA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370052-siga-technologies-up-7-after-fda-approval-of-smallpox-drug\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SIGA Technologies up 7% after FDA approval of smallpox drug</a></h4><ul><li>Siga's (<a href='https://seekingalpha.com/symbol/SIGA' title='SIGA Technologies Inc.'>SIGA</a> <font color='green'>+7.1%</font>)&nbsp;TPOXX (tecovirimat) is the first drug with&nbsp;<a href=\"https://www.prnewswire.com/news-releases/fda-approves-the-first-drug-with-an-indication-for-treatment-of-smallpox-300680846.html\" target=\"_blank\">an indication for</a> treatment of smallpox.</li></ul><div class=\"tiny-share-widget\" data-id=\"3370052\" data-linked=\"SIGA Technologies up 7% after FDA approval of smallpox drug\" data-tweet=\"$SIGA - SIGA Technologies up 7% after FDA approval of smallpox drug https://seekingalpha.com/news/3370052-siga-technologies-up-7-after-fda-approval-of-smallpox-drug?source=tweet\" data-url=\"https://seekingalpha.com/news/3370052-siga-technologies-up-7-after-fda-approval-of-smallpox-drug\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370047\" data-ts=\"1531508189\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNRO\" target=\"_blank\">MNRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370047-monro-upgraded-to-buy-goldman-seeing-promising-unit-growth-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Monro upgraded to Buy at Goldman, seeing promising unit growth potential</a></h4><ul>     <li>Monro Muffler (<a href='https://seekingalpha.com/symbol/MNRO' title='Monro, Inc.'>MNRO</a> <font color='green'>+6.2%</font>) jumps to a 52-week high after Goldman Sachs <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/07/12017930/monro-muffler-has-promising-unit-growth-potential-goldm\" target=\"_blank\">upgrades shares to Buy</a> from Neutral with a $71 price target, raised from $49, seeing an opportunity for the company to recapture same-store sales momentum.</li>     <li>Driven by a new senior management team and favorable demographics, Goldman believes MNRO boasts a promising unit growth story and a chance to regain its&nbsp;same-store sales momentum over the next three years.</li>     <li>Competition is&nbsp;fragmented, independent competitors face headwinds, and 75% of the company&rsquo;s stores are in just 10&nbsp;states, providing substantial growth opportunities, the firm says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3370047\" data-linked=\"Monro upgraded to Buy at Goldman, seeing promising unit growth potential\" data-tweet=\"$MNRO - Monro upgraded to Buy at Goldman, seeing promising unit growth potential https://seekingalpha.com/news/3370047-monro-upgraded-to-buy-goldman-seeing-promising-unit-growth-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/3370047-monro-upgraded-to-buy-goldman-seeing-promising-unit-growth-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370046\" data-ts=\"1531508115\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPCB\" target=\"_blank\">SPCB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370046-technology-top-5-gainers-losers-of-2_55-pm-07-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2.55 PM (07/13/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/SPCB' title='SuperCom, Ltd.'>SPCB</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CPAH' title='CounterPath Corporation'>CPAH</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/I' title='Intelsat SA'>I</a> <font color='green'>+8%</font>. OIBR-C <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/CCIH' title='ChinaCache International'>CCIH</a> <font color='green'>+7%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/GOGO' title='Gogo'>GOGO</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/CNTF' title='China TechFaith Wireless Communication Technology Limited'>CNTF</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/EGAN' title='eGain Communications Corp.'>EGAN</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/IOTS' title='Adesto Technologies'>IOTS</a> <font color='red'>-6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3370046\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2.55 PM (07/13/2018)\" data-tweet=\"$SPCB $SPCB $CPAH - Technology - Top 5 Gainers / Losers as of 2.55 PM (07/13/2018) https://seekingalpha.com/news/3370046-technology-top-5-gainers-losers-of-2_55-pm-07-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3370046-technology-top-5-gainers-losers-of-2_55-pm-07-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370044\" data-ts=\"1531507723\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RHHBY\" target=\"_blank\">RHHBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370044-fda-oks-expanded-use-for-roches-pct-assay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs expanded use for Roche&#39;s PCT assay</a></h4><ul><li>The FDA grants 510(k) clearance for Roche's (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a> <font color='green'>+1.3%</font>) Elecsys B&middot;R&middot;A&middot;H&middot;M&middot;S PCT assay for use as support for antibiotic treatment decisions in patients with suspected or confirmed sepsis, lower respiratory tract infections and acute bronchitis.</li><li>The test was originally cleared to evaluate the risk of progression to severe sepsis and septic shock in critically ill patients and 28-day mortality after diagnosis.</li><li>The test measures a proinflammatory blood biomarker called <a href=\"https://academic.oup.com/labmed/article/41/3/173/2504938\" target=\"_blank\">procalcitonin</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3370044\" data-linked=\"FDA OKs expanded use for Roche&#39;s PCT assay\" data-tweet=\"$RHHBY - FDA OKs expanded use for Roche&#39;s PCT assay https://seekingalpha.com/news/3370044-fda-oks-expanded-use-for-roches-pct-assay?source=tweet\" data-url=\"https://seekingalpha.com/news/3370044-fda-oks-expanded-use-for-roches-pct-assay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370040\" data-ts=\"1531506813\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKD\" target=\"_blank\">BKD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370040-brookdale-senior-living-skids-rbc-analyst-sees-soft-sector-fundamentals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brookdale Senior Living skids as RBC analyst sees soft sector fundamentals</a></h4><ul><li>Brookdale Senior Living (<a href='https://seekingalpha.com/symbol/BKD' title='Brookdale Senior Living Inc.'>BKD</a> <font color='red'>-4.8%</font>) fell as much as 6.8% after RBC analyst Frank Morgan says the senior housing market continues to see soft fundamental performance.</li><li>\"Senior housing occupancy continues to deteriorate amid growth in supply,\" he wrote in a note to clients, according to Bloomberg.</li><li>Q2 occupancy comparisons with year-ago--down 80 bps to 87.9%--likely suffered from the strong flu season, and occupancy to remain under pressure from recent and coming new facility openings.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3368580-brookdale-2-percent-premarket-shareholder-letter-citing-value-real-estate\" target=\"_blank\">Brookdale up 2% premarket on shareholder letter citing value of real estate</a> (July 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3370040\" data-linked=\"Brookdale Senior Living skids as RBC analyst sees soft sector fundamentals\" data-tweet=\"$BKD - Brookdale Senior Living skids as RBC analyst sees soft sector fundamentals https://seekingalpha.com/news/3370040-brookdale-senior-living-skids-rbc-analyst-sees-soft-sector-fundamentals?source=tweet\" data-url=\"https://seekingalpha.com/news/3370040-brookdale-senior-living-skids-rbc-analyst-sees-soft-sector-fundamentals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370032\" data-ts=\"1531504898\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNES\" target=\"_blank\">SNES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370032-energy-materials-top-5-gainers-losers-of-2-00-pm-07-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (07/13/2018)</a></h4><ul>     <li><b>Gainers:&nbsp;</b><a href='https://seekingalpha.com/symbol/SNES' title='SenesTech'>SNES</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/RCON' title='Recon Technology, Ltd.'>RCON</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/LONE' title='Lonestar Resources US Inc.'>LONE</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/TGC' title='Tengasco, Inc'>TGC</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/ANW' title='Aegean Marine Petroleum Network Inc.'>OTC:ANW</a> <font color='green'>+6%</font>.<b> </b></li><b> </b>     </ul><div class=\"tiny-share-widget\" data-id=\"3370032\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (07/13/2018)\" data-tweet=\"$SNES $SNES $RCON - Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (07/13/2018) https://seekingalpha.com/news/3370032-energy-materials-top-5-gainers-losers-of-2-00-pm-07-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3370032-energy-materials-top-5-gainers-losers-of-2-00-pm-07-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370031\" data-ts=\"1531504659\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370031-t-staying-course-on-time-warner-in-wake-of-doj-appeal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AT&amp;T staying course on Time Warner in wake of DOJ appeal</a></h4><ul>     <li><a href=\"https://www.cnbc.com/2018/07/13/att-time-warner-appeal-ceo-randall-stephenson-.html\" target=\"_blank\">There's no change</a> to AT&amp;T's (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color='red'>-1.9%</font>) approach to integrating the former Time Warner now that the Justice Dept. has appealed the court decision allowing the merger to proceed, CEO Randall Stephenson says.</li>    <li>\"We're about executing our plan,\" he tells CNBC from Sun Valley. \"We think the likelihood of this thing being reversed and overturned is really remote. It's a very narrow path that would have to be traveled to get this thing reversed in any way.\"</li>    <li>\"The merger is closed. We own Time Warner.\"</li>    <li>In credit ratings agencies, Fitch expects the government's appeal to fail, though anything's possible with the three judges who are considering the appeal. And Moody's says its ratings on AT&amp;T are unchanged following the news.</li>    <li>The appeal may last five or six months, Stephenson says.</li>    <li>Earlier, AT&amp;T was <a href=\"https://seekingalpha.com/news/3369912-t-bull-pulls-reins-doj-appeal\" target=\"_blank\">cut at Raymond James</a> on the news. Meanwhile, Oppenheimer agrees with Stephenson that the appeal has a \"low probability\" of success. \"Unfortunately, it is also likely to keep T's stock under pressure until it is resolved,\" says analyst Timothy Horan.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3370031\" data-linked=\"AT&amp;T staying course on Time Warner in wake of DOJ appeal\" data-tweet=\"$T - AT&amp;T staying course on Time Warner in wake of DOJ appeal https://seekingalpha.com/news/3370031-t-staying-course-on-time-warner-in-wake-of-doj-appeal?source=tweet\" data-url=\"https://seekingalpha.com/news/3370031-t-staying-course-on-time-warner-in-wake-of-doj-appeal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>58&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370029\" data-ts=\"1531503680\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KSHB\" target=\"_blank\">KSHB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370029-kush-bottles-down-4_2-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kush Bottles down 4.2% post Q3 results</a></h4><ul><li>Kush Bottles (<a href='https://seekingalpha.com/symbol/KSHB' title='KushCo Holdings, Inc.'>OTCQB:KSHB</a> <font color='red'>-4.2%</font>) <u><a href=\"https://seekingalpha.com/filing/4098083\" target=\"_blank\">reports Q3</a></u>&nbsp;revenue growth of 173.3% Y/Y to $12.9M.</li><li>Gross margin&nbsp;<font color='red'>declined 720 bps</font>&nbsp;to 28.3%, which is attributed to increased business in the lower margin vaporizer and cartridge product segments.</li><li>Working capital was $15.8M &amp; cash balance was $3.6M, this increase in cash was primarily a result of a $6M equity investment by the Company&rsquo;s strategic partner, Merida Capital Partners.</li><li>Kush Bottles completed a registered direct offering, generating net proceeds of ~$32.9M to the Company.</li><li>The company also acquired Zack Darling Creative Associates, along with its wholly-owned subsidiary, The Hybrid Creative.</li><li>And closed acquisition of Summit Innovations, marking Kush Bottles&rsquo; entry into the hydrocarbon and solvent market.</li><li>The company launched a new division, Koleto Packaging Solutions that will be focused on building proprietary and highly customizable products for the cannabis.</li><li>&ldquo;As we head toward the end of our fiscal year we&nbsp;look forward to driving continued organic and acquisitive growth, supported by our&nbsp;strong leadership team and expanded, diversified offering,&rdquo; said Nick Kovacevich, Chairman and CEO.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3369806-kush-bottles-beats-revenue\" target=\"_blank\">Kush Bottles beats on revenue</a> (July 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3370029\" data-linked=\"Kush Bottles down 4.2% post Q3 results\" data-tweet=\"$KSHB - Kush Bottles down 4.2% post Q3 results https://seekingalpha.com/news/3370029-kush-bottles-down-4_2-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3370029-kush-bottles-down-4_2-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370028\" data-ts=\"1531502630\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AR\" target=\"_blank\">AR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370028-hedgeye-long-antero-resources-short-antero-midstream\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hedgeye: Long Antero Resources, short Antero Midstream</a></h4><ul><li><a href=\"https://app.hedgeye.com/\" target=\"_blank\">Hedgeye analyst</a> Alec Richards adds a long of Antero Resources (<a href='https://seekingalpha.com/symbol/AR' title='Antero Resources Corporation'>AR</a> <font color='green'>+1.5%</font>) to the Best Ideas list, while recommending a short of Antero Midsteam (<a href='https://seekingalpha.com/symbol/AMGP' title='Antero Midstream GP LP'>AMGP</a> <font color='red'>-4.5%</font>).</li><li>He sees&nbsp;<font color='green'>20-40% upside</font>&nbsp;for AR, and&nbsp;<font color='red'>20-50% downside</font>&nbsp;for AMGP.</li><li>A call to discuss is set for July 19.</li></ul><div class=\"tiny-share-widget\" data-id=\"3370028\" data-linked=\"Hedgeye: Long Antero Resources, short Antero Midstream\" data-tweet=\"$AR $AR $AM - Hedgeye: Long Antero Resources, short Antero Midstream https://seekingalpha.com/news/3370028-hedgeye-long-antero-resources-short-antero-midstream?source=tweet\" data-url=\"https://seekingalpha.com/news/3370028-hedgeye-long-antero-resources-short-antero-midstream\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370027\" data-ts=\"1531502611\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370027-amazon-anxiety-in-network-switches-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon anxiety in network switches sector</a></h4><ul><li>Amazon (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color='green'>+0.7%</font>) is considering making a <a href=\"https://www.theinformation.com/articles/amazon-web-services-targets-cisco-in-networking\" target=\"_blank\">move</a> into network switches, according to an exclusive posted by The Information.</li><li>Sources indicate that AWS is considering selling its own networking switches for business customers as part of a strong enterprise move.</li><li>Shares of Cisco (<a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a> <font color='red'>-2.3%</font>), Juniper Networks (<a href='https://seekingalpha.com/symbol/JNPR' title='Juniper Networks'>JNPR</a> <font color='red'>-2.2%</font>) and Arista Networks (<a href='https://seekingalpha.com/symbol/ANET' title='Arista Networks, Inc.'>ANET</a> <font color='red'>-3.9%</font>) have all moved lower off the development.</li></ul><div class=\"tiny-share-widget\" data-id=\"3370027\" data-linked=\"Amazon anxiety in network switches sector\" data-tweet=\"$AMZN $AMZN $CSCO - Amazon anxiety in network switches sector https://seekingalpha.com/news/3370027-amazon-anxiety-in-network-switches-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3370027-amazon-anxiety-in-network-switches-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>94&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370020\" data-ts=\"1531501485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TREE\" target=\"_blank\">TREE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370020-financials-top-gainers-losers-of-1-00-pm-07-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM (07/13/2018)</a></h4><ul><li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/TREE' title='LendingTree, Inc.'>TREE</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/LX' title='LexinFintech Holdings Ltd. ADS'>LX</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/LEJU' title='Leju Holdings Limited'>LEJU</a> <font color='red'>-4.4%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3370020\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM (07/13/2018)\" data-tweet=\"$TREE $TREE $LX - Financials - Top Gainers / Losers as of 1:00 PM (07/13/2018) https://seekingalpha.com/news/3370020-financials-top-gainers-losers-of-1-00-pm-07-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3370020-financials-top-gainers-losers-of-1-00-pm-07-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370019\" data-ts=\"1531501357\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XRX\" target=\"_blank\">XRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370019-xerox-higher-on-talk-of-unit-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xerox higher on talk of unit sale</a></h4><ul> <li>Xerox (<a href='https://seekingalpha.com/symbol/XRX' title='Xerox Corporation'>XRX</a> <font color='green'>+0.7%</font>) moves higher after Reuters <a href=\"https://www.reuters.com/article/us-xerox-leasingfinance/xerox-explores-sale-of-leasing-finance-unit-sources-idUSKBN1K32D9\" target=\"_blank\">reports</a> the company is exploring a sale of it lease financing unit.</li> <li>Sources indicate that the company thinks it will be more attractive to potential bidders without the unit weighing down its debt load.</li> <li>Xerox hasn't issued a statement on the report.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3370019\" data-linked=\"Xerox higher on talk of unit sale\" data-tweet=\"$XRX - Xerox higher on talk of unit sale https://seekingalpha.com/news/3370019-xerox-higher-on-talk-of-unit-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3370019-xerox-higher-on-talk-of-unit-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370016\" data-ts=\"1531500345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KB\" target=\"_blank\">KB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370016-kb-financial-perks-up-almost-erasing-decline-since-monday\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KB Financial perks up, almost erasing decline since Monday</a></h4><ul><li>KB Financial (NYSE:<a href='https://seekingalpha.com/symbol/KB' title='KB Financial Group Inc.'>KB</a>)&nbsp;<font color='green'>gains 2.7%</font>&nbsp;in midday trading, regaining much of the ground it lost since Monday, with no obvious news to explain the activity.</li><li>Some 360,292 shares traded so far, more than twice its three-month daily average of 153,351 shares.</li><li>At yesterday's close KB had fallen 3.9% from its Monday close of $49.30.</li></ul><div class=\"tiny-share-widget\" data-id=\"3370016\" data-linked=\"KB Financial perks up, almost erasing decline since Monday\" data-tweet=\"$KB - KB Financial perks up, almost erasing decline since Monday https://seekingalpha.com/news/3370016-kb-financial-perks-up-almost-erasing-decline-since-monday?source=tweet\" data-url=\"https://seekingalpha.com/news/3370016-kb-financial-perks-up-almost-erasing-decline-since-monday\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370014\" data-ts=\"1531499871\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOC\" target=\"_blank\">BIOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370014-midday-gainers-losers-07-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (07/13/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a> <font color='green'>+73%</font>. <a href='https://seekingalpha.com/symbol/PIXY' title='ShiftPixy'>PIXY</a> <font color='green'>+55%</font>. <a href='https://seekingalpha.com/symbol/SNES' title='SenesTech'>SNES</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis Inc.'>ADXS</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/CFMS' title='ConforMIS'>CFMS</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/IFRX' title='InflaRx N.V.'>IFRX</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/ACHN' title='Achillion Pharmaceuticals, Inc.'>ACHN</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/RUBI' title='The Rubicon Project, Inc.'>RUBI</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/ZGNX' title='Zogenix, Inc.'>ZGNX</a> <font color='green'>+11%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> <font color='red'>-36%</font>. <a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/NVRO' title='Nevro'>NVRO</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/STAF' title='Staffing 360 Solutions, Inc.'>STAF</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/GOGO' title='Gogo'>GOGO</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CNTF' title='China TechFaith Wireless Communication Technology Limited'>CNTF</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/INGR' title='Ingredion, Inc.'>INGR</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/CTMX' title='CytomX Therapeutics'>CTMX</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/UUU' title='Universal Security Instruments, Inc'>UUU</a> <font color='red'>-9%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3370014\" data-linked=\"Midday Gainers / Losers (07/13/2018)\" data-tweet=\"$BIOC $BIOC $PIXY - Midday Gainers / Losers (07/13/2018) https://seekingalpha.com/news/3370014-midday-gainers-losers-07-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3370014-midday-gainers-losers-07-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370008\" data-ts=\"1531498701\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACIA\" target=\"_blank\">ACIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370008-zte-suppliers-move-commerce-dept-lifts-ban\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ZTE suppliers move as Commerce Dept. lifts ban</a></h4><ul>   <li>Acacia Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/ACIA' title='Acacia Communications'>ACIA</a>) has <font color='green'>jumped 3%</font>, and Oclaro (NASDAQ:<a href='https://seekingalpha.com/symbol/OCLR' title='Oclaro, Inc.'>OCLR</a>) has jumped to a <font color='green'>gain of 0.8%</font>, after the Commerce Dept. <a href=\"https://www.reuters.com/article/us-usa-trade-china-zte/u-s-ban-on-chinas-zte-lifted-idUSKBN1K32CN?il=0\" target=\"_blank\">acts to lift a ban</a> on selling goods to China's ZTE (<a href=\"http://seekingalpha.com/symbol/ZTCOF\" target=\"_blank\">ZTCOF</a> <font color='red'>-3.6%</font>).</li>    <li>The department removed ZTE from its \"denied persons list\" as of today.</li>    <li>Commerce had said it would work toward lifting the ban after a <a href=\"https://seekingalpha.com/news/3369407-u-s-zte-reach-deal-400m-escrow-move-toward-lifting-ban\" target=\"_blank\">$400M escrow account</a> was set up, along with a $1B penalty on the company.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3370008\" data-linked=\"ZTE suppliers move as Commerce Dept. lifts ban\" data-tweet=\"$ACIA $ACIA $OCLR - ZTE suppliers move as Commerce Dept. lifts ban https://seekingalpha.com/news/3370008-zte-suppliers-move-commerce-dept-lifts-ban?source=tweet\" data-url=\"https://seekingalpha.com/news/3370008-zte-suppliers-move-commerce-dept-lifts-ban\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370005\" data-ts=\"1531497702\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNKO\" target=\"_blank\">FNKO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370005-consumer-top-gainers-losers-of-12-00-pm-7-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm (7/13/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FNKO' title='Funko, Inc.'>FNKO</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/MNRO' title='Monro, Inc.'>MNRO</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/FAMI' title='Farmmi Inc.'>FAMI</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/SEED' title='Origin Agritech Limited'>SEED</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/XELB' title='Xcel Brands, Inc.'>XELB</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/INGR' title='Ingredion, Inc.'>INGR</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/VUZI' title='Vuzix Corp'>VUZI</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/MSN' title='Emerson Radio Corp'>MSN</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3370005\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm (7/13/2018)\" data-tweet=\"$FNKO $FNKO $MNRO - Consumer - Top Gainers / Losers as of 12:00 pm (7/13/2018) https://seekingalpha.com/news/3370005-consumer-top-gainers-losers-of-12-00-pm-7-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3370005-consumer-top-gainers-losers-of-12-00-pm-7-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370001\" data-ts=\"1531497499\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASPU\" target=\"_blank\">ASPU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370001-aspen-group-down-2-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aspen Group down 2% post Q4 results</a></h4><ul><li>Aspen Group (<a href='https://seekingalpha.com/symbol/ASPU' title='Aspen Group Inc.'>ASPU</a> <font color='red'>-1.9%</font>) <u><a href=\"https://seekingalpha.com/filing/4098077\" target=\"_blank\">reports Q4</a></u>&nbsp;revenue growth of 68% Y/Y to $7.2M.</li><li>Aspen new student enrollments totaled to 1,273; of which Aspen University accounted for 1,096 &amp; United States University accounted for 177 new student.</li><li>Aspen University &amp; United States University students paying tuition and fees through a monthly payment method were 4,532 (+48% Y/Y) &amp; 293 (+43.6% Y/Y) respectively.</li><li>Those 4,532 students were 70% of Aspen University&rsquo;s total active student body of 6,500 &amp; 293 students were 53% of United States University total active student body of 557.</li><li>Gross profit increased to $3.5M (+35% Y/Y); Aspen University gross profit was 57%, while USU gross profit equaled 27%.</li><li>Aspen University marketing and promotional costs represented 23% of Aspen University revenues, while USU marketing and promotional costs equaled 35% of USU revenues.</li><li>Adj. EBITDA totaled to $(1M) while, cash &amp; equivalents was $14.6M (+421.4% Y/Y).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3369882-aspen-reports-fy-results\" target=\"_blank\">Aspen reports FY results</a> (July 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3370001\" data-linked=\"Aspen Group down 2% post Q4 results\" data-tweet=\"$ASPU - Aspen Group down 2% post Q4 results https://seekingalpha.com/news/3370001-aspen-group-down-2-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3370001-aspen-group-down-2-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370002\" data-ts=\"1531497144\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRQ\" target=\"_blank\">DRQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370002-dril-quip-enters-subsea-production-systems-deal-for-sea-lion-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dril-Quip enters subsea production systems deal for Sea Lion project</a></h4><ul>     <li>Dril-Quip (<a href='https://seekingalpha.com/symbol/DRQ' title='Dril-Quip, Inc.'>DRQ</a> <font color='green'>+4.6%</font>) shoots higher after saying it plans to <a href=\"https://seekingalpha.com/pr/17215403-dril-quip-enters-letter-intent-subsea-production-systems-sea-lion-project\" target=\"_blank\">provide subsea production systems</a> to Premier Oil (<a href='https://seekingalpha.com/symbol/PMOIF' title='Premier Oil plc'>OTCPK:PMOIF</a>) for the Sea Lion phase 1 development off the Falkland Islands.</li>     <li>DRQ says the scope of work includes plans for 23 subsea production systems, including wellheads, trees, control systems, associated production and injection manifolds, subsea umbilicals and related services.</li><li>DRQ would begin pre-sanction engineering work in August, but says a formal contract award is subject to agreement of a definitive contract and Premier taking a final investment decision.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3370002\" data-linked=\"Dril-Quip enters subsea production systems deal for Sea Lion project\" data-tweet=\"$DRQ $DRQ $PMOIF - Dril-Quip enters subsea production systems deal for Sea Lion project https://seekingalpha.com/news/3370002-dril-quip-enters-subsea-production-systems-deal-for-sea-lion-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3370002-dril-quip-enters-subsea-production-systems-deal-for-sea-lion-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3370000\" data-ts=\"1531496596\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOGO\" target=\"_blank\">GOGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3370000-gogo-slides-after-business-plan-call-northland-skeptical\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gogo slides after business plan call; Northland skeptical</a></h4><ul>    <li>Gogo (NASDAQ:<a href='https://seekingalpha.com/symbol/GOGO' title='Gogo'>GOGO</a>) has <font color='red'>turned 11.5% lower</font> after the company's conference call discussing its <a href=\"https://seekingalpha.com/news/3369829-gogo-plus-6_6-percent-restructuring-plan\" target=\"_blank\">new business plan</a>, Gogo 2020.</li>    <li>&ldquo;The difference in view of potential strategic partners of our value and Wall Street&rsquo;s sense of our value is as striking as I have ever seen,&rdquo; CEO Oakleigh Thorne said.</li>    <li>The company's targeting break-even free cash flow for 2020 with a plan aimed at cost structure improvement along with balance sheet strengthening and revenue growth.</li>    <li>Part of the call centered on debt refinancing, particularly the convertible notes due March 2020, and refinancing of those will be considered in the context of potential strategic deals and dilution impact, says CFO Barry Rowan. \"No one is more concerned about equity dilution than Oak [Thorne],\" he says, and refinancing doesn't have to happen all at once. (h/t Bloomberg)</li>    <li>Meanwhile, Northland Securities isn't buying the new plan. \"We&rsquo;ve seen this movie before with enticing the street with impressive out year EBITA growth targets,\" says analyst Paul Penney, who sees \"minimal equity value left in GOGO's shares.\"</li>    <li>Most of the company's wins with airlines have come from \"funded deals,\" he says, and he questions how debt service costs won't go up, risking the break-even FCF projection. He's projecting $848.4M revenues vs. the company's sunnier outlook of $865M-$935M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3370000\" data-linked=\"Gogo slides after business plan call; Northland skeptical\" data-tweet=\"$GOGO - Gogo slides after business plan call; Northland skeptical https://seekingalpha.com/news/3370000-gogo-slides-after-business-plan-call-northland-skeptical?source=tweet\" data-url=\"https://seekingalpha.com/news/3370000-gogo-slides-after-business-plan-call-northland-skeptical\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369998\" data-ts=\"1531496006\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIPT\" target=\"_blank\">AIPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369998-precision-therapeutics-nabs-european-patent-covering-streamway-shares-up-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Precision Therapeutics nabs European patent covering Streamway; shares up 10%</a></h4><ul><li>Thinly traded nano cap Precision Therapeutics (<a href='https://seekingalpha.com/symbol/AIPT' title='Precision Therapeutics Inc.'>AIPT</a> <font color='green'>+9.5%</font>) is up on more than a 10x surge in volume on the heels of its <a href=\"https://seekingalpha.com/pr/17215353-precision-therapeutics-granted-european-patent-automated-direct-drain-medical-fluid-disposal\" target=\"_blank\">announcement </a>that the European Patent Office has issued it a new patent, No. 2948200, covering its CE-Mark'd STREAMWAY fluid disposal system.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369998\" data-linked=\"Precision Therapeutics nabs European patent covering Streamway; shares up 10%\" data-tweet=\"$AIPT $POAI - Precision Therapeutics nabs European patent covering Streamway; shares up 10% https://seekingalpha.com/news/3369998-precision-therapeutics-nabs-european-patent-covering-streamway-shares-up-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3369998-precision-therapeutics-nabs-european-patent-covering-streamway-shares-up-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369996\" data-ts=\"1531495479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITGR\" target=\"_blank\">ITGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369996-integer-holdings-concludes-redemption-of-high-priced-debt-shares-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Integer Holdings concludes redemption of high-priced debt; shares up 6%</a></h4><ul><li>Thinly traded Integer Holdings (<a href='https://seekingalpha.com/symbol/ITGR' title='Integer Holdings Corporation'>ITGR</a> <font color='green'>+6.3%</font>) is up on modestly higher volume. Shares have rallied over&nbsp;<font color='green'>7%</font>&nbsp;since breaking resistance at $68 yesterday.</li><li>Yesterday after the close, the company filed an <a href=\"https://www.sec.gov/Archives/edgar/data/1114483/000111448318000020/itgr-20180712indenturedisc.htm\" target=\"_blank\">8-K</a> disclosing that it and subsidiary Greatbatch Ltd. completed the redemption of $360M aggregate principal amount of its 9.125% Senior Notes due 2023.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369996\" data-linked=\"Integer Holdings concludes redemption of high-priced debt; shares up 6%\" data-tweet=\"$ITGR - Integer Holdings concludes redemption of high-priced debt; shares up 6% https://seekingalpha.com/news/3369996-integer-holdings-concludes-redemption-of-high-priced-debt-shares-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3369996-integer-holdings-concludes-redemption-of-high-priced-debt-shares-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369991\" data-ts=\"1531494414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOC\" target=\"_blank\">BIOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369991-healthcare-top-5-gainers-losers-of-11-00-7-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am (7/13/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a> <font color='green'>+59%</font>. <a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis Inc.'>ADXS</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/ATXI' title='Avenue Therapeutics'>ATXI</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/AIPT' title='Precision Therapeutics Inc.'>AIPT</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> <font color='red'>-35%</font>. <a href='https://seekingalpha.com/symbol/NVRO' title='Nevro'>NVRO</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/IMRN' title='Immuron Limited'>IMRN</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/KMPH' title='KemPharm'>KMPH</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/BTAI' title='BioXcel Therapeutics'>BTAI</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369991\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am (7/13/2018)\" data-tweet=\"$BIOC $BIOC $ADXS - Healthcare - Top 5 Gainers / Losers as of 11:00 am (7/13/2018) https://seekingalpha.com/news/3369991-healthcare-top-5-gainers-losers-of-11-00-7-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3369991-healthcare-top-5-gainers-losers-of-11-00-7-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369992\" data-ts=\"1531494414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOME\" target=\"_blank\">HOME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369992-home-continues-dallas-fort-worth-area-expansion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">At Home continues Dallas-Fort Worth area expansion</a></h4><ul>     <li>At Home Group (<a href='https://seekingalpha.com/symbol/HOME' title='At Home Group'>HOME</a> <font color='green'>+2.4%</font>) has <a href=\"https://seekingalpha.com/pr/17215511-home-continues-dallas-fort-worth-area-expansion-three-new-store-openings\" target=\"_blank\">expanded its presence</a> in the Dallas-Fort Worth area with the opening of three new stores in Plano, Garland and Mansfield.</li>     <li>All three of these new stores will be open by early fall, bringing the total At Home store count to 11 in Dallas-Fort Worth and 33 in Texas.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369992\" data-linked=\"At Home continues Dallas-Fort Worth area expansion\" data-tweet=\"$HOME - At Home continues Dallas-Fort Worth area expansion https://seekingalpha.com/news/3369992-home-continues-dallas-fort-worth-area-expansion?source=tweet\" data-url=\"https://seekingalpha.com/news/3369992-home-continues-dallas-fort-worth-area-expansion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369984\" data-ts=\"1531493061\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MA\" target=\"_blank\">MA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369984-mastercard-and-visa-dip-after-major-banks-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mastercard and Visa dip after major banks report</a></h4><ul> <li>Mastercard (<a href='https://seekingalpha.com/symbol/MA' title='Mastercard, Inc.'>MA</a> <font color='red'>-1%</font>) and Visa (<a href='https://seekingalpha.com/symbol/V' title='Visa Inc.'>V</a> <font color='red'>-0.8%</font>) are slightly lower after a round of earnings reports from major banks.</li> <li>JPMorgan analyst Sanjay Sakhrani says card activity from JPMorgan, Wells Fargo and Citigroup disappointed by showing a \"mild\" deceleration in volume growth.</li> <li>Source: Bloomberg</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3369984\" data-linked=\"Mastercard and Visa dip after major banks report\" data-tweet=\"$MA $MA $V - Mastercard and Visa dip after major banks report https://seekingalpha.com/news/3369984-mastercard-and-visa-dip-after-major-banks-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3369984-mastercard-and-visa-dip-after-major-banks-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369980\" data-ts=\"1531492412\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LKQ\" target=\"_blank\">LKQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369980-lkq-files-for-mixed-shelf-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LKQ files for mixed shelf offering</a></h4><ul>     <li>LKQ (<a href='https://seekingalpha.com/symbol/LKQ' title='LKQ Corporation'>LKQ</a> <font color='green'>+1.1%</font>)&nbsp; files mixed securities shelf offering.</li>     <li><a href=\"https://www.sec.gov/Archives/edgar/data/1065696/000106569618000047/forms-3asr06x18.htm\" target=\"_blank\">SEC Form S-3</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3369980\" data-linked=\"LKQ files for mixed shelf offering\" data-tweet=\"$LKQ - LKQ files for mixed shelf offering https://seekingalpha.com/news/3369980-lkq-files-for-mixed-shelf-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3369980-lkq-files-for-mixed-shelf-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369978\" data-ts=\"1531492292\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OYIEF\" target=\"_blank\">OYIEF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369978-ocean-yield-down-4_6-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocean Yield down 4.6% post Q2 results</a></h4><ul><li>Ocean Yield (<a href='https://seekingalpha.com/symbol/OYIEF' title='Ocean Yield ASA'>OTCQX:OYIEF</a> <font color='red'>-4.6%</font>) <u><a href=\"https://www.oceanyield.no/Investor-Relations/Reports-and-presentations\" target=\"_blank\">reports Q2</a></u>&nbsp;revenue growth of 15.7% Y/Y to $95.1M.</li><li>EBITDA was $84.3M (+13.5% Y/Y) and EBITDA adjusted for finance lease effects was $95.1M (+14.4% Y/Y).</li><li>Cash &amp; equivalents were $266M (+113.3% Q/Q) &amp; declared dividend of $0.1910 per share which is an increase of 0.05 cents Q/Q.</li><li>The company delivered 2 handy-size dry bulk vessels with long-term charters, which were acquired during Q1 2018.</li><li>Acquired of four 2014 built 3,800 TEU container vessels with 12-year bareboat charters to companies owned and guaranteed by CMB NV.</li><li>The company completed a new 5-year unsecured bond issue of NOK 750M carrying a coupon of NIBOR +3.65% p.a. and repaid in early July the outstanding amounts of NOK 661M under the bond loan OCY02.</li><li>Also signed loan agreements with a total amount of $330M for the long-term bank financing of recent acquisitions.</li><li>Outlook: The Company will take delivery of another 11 vessels on long term charter, which will further contribute to increased earnings and dividend capacity.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3369841-ocean-yield-reports-q2-results\" target=\"_blank\">Ocean Yield reports Q2 results</a> (July 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369978\" data-linked=\"Ocean Yield down 4.6% post Q2 results\" data-tweet=\"$OYIEF - Ocean Yield down 4.6% post Q2 results https://seekingalpha.com/news/3369978-ocean-yield-down-4_6-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3369978-ocean-yield-down-4_6-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369976\" data-ts=\"1531491257\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAFM\" target=\"_blank\">SAFM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369976-sanderson-farms-and-pilgrims-price-drop-on-goldman-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sanderson Farms and Pilgrim&#39;s Price drop on Goldman warning</a></h4><ul> <li>Sanderson Farms (<a href='https://seekingalpha.com/symbol/SAFM' title='Sanderson Farms, Inc.'>SAFM</a> <font color='red'>-3.3%</font>) trades lower after Goldman Sachs warns on soft summer pricing and a potential deceleration in industry production during the second half of the year.</li> <li>Analyst Adam Samuelson drops his Q3 and Q4 earnings estimates on Sanderson Farms due to the pricing pressure.</li> <li>Pilgrim's Pride (<a href='https://seekingalpha.com/symbol/PPC' title='Pilgrim&#39;s Pride Corporation'>PPC</a> <font color='red'>-1.5%</font>) is also showing a loss on the day.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3369976\" data-linked=\"Sanderson Farms and Pilgrim&#39;s Price drop on Goldman warning\" data-tweet=\"$SAFM $SAFM $PPC - Sanderson Farms and Pilgrim&#39;s Price drop on Goldman warning https://seekingalpha.com/news/3369976-sanderson-farms-and-pilgrims-price-drop-on-goldman-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3369976-sanderson-farms-and-pilgrims-price-drop-on-goldman-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369974\" data-ts=\"1531490957\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVRO\" target=\"_blank\">NVRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369974-nevro-axes-sales-chief-shares-down-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nevro axes sales chief; shares down 15%</a></h4><ul><li>Nevro (<a href='https://seekingalpha.com/symbol/NVRO' title='Nevro'>NVRO</a> <font color='red'>-14.9%</font>) slumps on double normal volume on the heels of a terse <a href=\"https://www.sec.gov/Archives/edgar/data/1444380/000119312518217270/d431108d8k.htm\" target=\"_blank\">disclosure </a>that it terminated the employment of VP Worldwide Sales James Alecxih. No reason for the action is provided.</li><li>Shares have sold off almost&nbsp;<font color='red'>40%</font>&nbsp;since early May.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321674-fda-oks-nevros-senza-ii-scs-shares-ahead-16-percent\" target=\"_blank\">FDA OKs Nevro's Senza II SCS; shares ahead 16%</a> (Jan. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369974\" data-linked=\"Nevro axes sales chief; shares down 15%\" data-tweet=\"$NVRO - Nevro axes sales chief; shares down 15% https://seekingalpha.com/news/3369974-nevro-axes-sales-chief-shares-down-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3369974-nevro-axes-sales-chief-shares-down-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369965\" data-ts=\"1531489301\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RH\" target=\"_blank\">RH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369965-rh-updates-on-china-sourcing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RH updates on China sourcing</a></h4><ul> <li>RH (<a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a> <font color='green'>+4.6%</font>) issues a clarification on how much product the company sources from China.</li>     <li>RH statement:&nbsp;\"The Company expects to source approximately 35% of its product from       China in fiscal 2018, and that imports from China will be approximately       25% to 30% in fiscal 2019. In fiscal 2017, approximately 40% of RH       product was sourced from China.\"</li>     <li>RH says it believes that it can mitigate the impact of the proposed 10%       tariff on its business to the point that there would be an immaterial       impact on FY18 and FY19 results.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17215583-rh-provides-clarification-product-sourcing-china\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3369965\" data-linked=\"RH updates on China sourcing\" data-tweet=\"$RH - RH updates on China sourcing https://seekingalpha.com/news/3369965-rh-updates-on-china-sourcing?source=tweet\" data-url=\"https://seekingalpha.com/news/3369965-rh-updates-on-china-sourcing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369962\" data-ts=\"1531488356\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WWE\" target=\"_blank\">WWE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369962-wweplus-3_9-morgan-stanley-counts-out-rivals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WWE +3.9% as Morgan Stanley counts out rivals</a></h4><ul>   <li>World Wrestling Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/WWE' title='World Wrestling Entertainment, Inc.'>WWE</a>) is <font color='green'>up 3.9%</font> after getting a Street-high price target of $100 from Morgan Stanley, soaking in the company's new <a href=\"https://seekingalpha.com/news/3366396-wwe-plus-8_1-percent-new-u-s-flagship-deals-usa-fox\" target=\"_blank\">U.S. rights deal</a>.</li>    <li>The firm boosted its target from $58. The $100 target implies 34% upside.</li>    <li>\"To some extent the match is over as WWE is likely the fastest growing earnings story\" in analyst Benjamin Swinburne's coverage area, he writes. Visibility into revenue tied to the new rights deal is \"extremely high,\" and he expects adjusted OIBDA to get to $500M in 2021 from $130M last year. (h/t Bloomberg)</li>    <li>Rights renewals in the UK and India are smaller than the U.S., but still ahead.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369962\" data-linked=\"WWE +3.9% as Morgan Stanley counts out rivals\" data-tweet=\"$WWE - WWE +3.9% as Morgan Stanley counts out rivals https://seekingalpha.com/news/3369962-wweplus-3_9-morgan-stanley-counts-out-rivals?source=tweet\" data-url=\"https://seekingalpha.com/news/3369962-wweplus-3_9-morgan-stanley-counts-out-rivals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369958\" data-ts=\"1531487842\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OGEN\" target=\"_blank\">OGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369958-premarket-losers-of-9-05-07-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (07/13/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a>&nbsp;<font color='red'>-30%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3369940-oragenics-prices-equity-offering-shares-31-percent-premarket\" target=\"_blank\">pricing</a> of equity offering.</li>     <li><a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a>&nbsp;<font color='red'>-17%</font>&nbsp;on definitive <a href=\"https://seekingalpha.com/news/3369631-izea-signs-definitive-agreement-acquire-tapinfluence\" target=\"_blank\">agreement</a> to acquire TapInfluence.</li>     <li><a href='https://seekingalpha.com/symbol/INGR' title='Ingredion, Inc.'>INGR</a>&nbsp;<font color='red'>-9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3369840-ingredion-minus-4_3-percent-forecast-cut-cost-savings-program\" target=\"_blank\">forecast cut</a>, cost-savings program.</li>     <li><a href='https://seekingalpha.com/symbol/SSLJ' title='SSLJ. COM LTD'>SSLJ</a>&nbsp;<font color='red'>-9%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/CNTF' title='China TechFaith Wireless Communication Technology Limited'>CNTF</a>&nbsp;<font color='red'>-8%</font>&nbsp;reversing yesterday gain.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369958\" data-linked=\"Premarket Losers as of 9:05 am (07/13/2018)\" data-tweet=\"$OGEN $OGEN $IZEA - Premarket Losers as of 9:05 am (07/13/2018) https://seekingalpha.com/news/3369958-premarket-losers-of-9-05-07-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3369958-premarket-losers-of-9-05-07-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369941\" data-ts=\"1531487836\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATOS\" target=\"_blank\">ATOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369941-atossa-genetics-opens-enrollment-in-mid-stage-study-of-endoxifen-in-breast-cancer-shares-up-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atossa Genetics opens enrollment in mid-stage study of Endoxifen in breast cancer; shares up 5% premarket</a></h4><ul><li>Thinly traded nano cap Atossa Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics, Inc.'>ATOS</a>) is is up&nbsp;<font color='green'>5%</font>&nbsp;premarket on modest volume on the heels of its <a href=\"https://seekingalpha.com/pr/17215482-atossa-genetics-opens-enrollment-phase-2-study-oral-endoxifen-treat-breast-cancer\" target=\"_blank\">announcement </a>that enrollment is underway in an Australia-based Phase 2 clinical trial evaluating oral Endoxifen in breast cancer.</li><li>The pilot phase will enroll up to eight participants with ER+/HER2- Stage 1 or Stage 2 invasive breast cancer who will receive treatment for at least 21 days from the time of diagnosis up to the day of surgery. If anti-tumor activity is observed in at least two patients, then an additional 17 will be enrolled.</li><li>The primary endpoint is response rate as measured by a biomarker called Ki-67.</li><li>Endoxifen is an active metabolite of tamoxifen, the active ingredient in AstraZeneca's Nolvadex (the company stopped making it in June 2006).</li></ul><div class=\"tiny-share-widget\" data-id=\"3369941\" data-linked=\"Atossa Genetics opens enrollment in mid-stage study of Endoxifen in breast cancer; shares up 5% premarket\" data-tweet=\"$ATOS - Atossa Genetics opens enrollment in mid-stage study of Endoxifen in breast cancer; shares up 5% premarket https://seekingalpha.com/news/3369941-atossa-genetics-opens-enrollment-in-mid-stage-study-of-endoxifen-in-breast-cancer-shares-up-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3369941-atossa-genetics-opens-enrollment-in-mid-stage-study-of-endoxifen-in-breast-cancer-shares-up-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369955\" data-ts=\"1531487473\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PIXY\" target=\"_blank\">PIXY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369955-premarket-gainers-of-9-05-07-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (07/13/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/PIXY' title='ShiftPixy'>PIXY</a> <font color='green'>+42%</font>&nbsp;after posting FQ3 <a href=\"https://seekingalpha.com/news/3369917-shiftpixy-soars-posting-fq3-update\" target=\"_blank\">update</a>.</li><li><a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis Inc.'>ADXS</a> <font color='green'>+35%</font>&nbsp;as FDA <a href=\"https://seekingalpha.com/news/3369939-fda-lifts-clinical-hold-advaxis-study-axalimogene-filolisbac-shares-61-percent-premarket\" target=\"_blank\">lifts</a> clinical hold on Advaxis study of axalimogene filolisbac.</li><li><a href='https://seekingalpha.com/symbol/AIPT' title='Precision Therapeutics Inc.'>AIPT</a> <font color='green'>+27%</font>&nbsp;on receiving European Patent for STREAMWAY System for automated, direct-to-drain&nbsp;medical fluid disposal.</li><li><a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a> <font color='green'>+18%</font>&nbsp;on marketing and distribution <a href=\"https://seekingalpha.com/news/3369948-biocept-announces-marketing-distribution-agreement-alliance-global-fz\" target=\"_blank\">agreement</a> with Alliance Global FZ.</li><li><a href='https://seekingalpha.com/symbol/SNES' title='SenesTech'>SNES</a> <font color='green'>+14%</font>.</li><li><a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color='green'>+14%&nbsp;</font>on positive analyst <a href=\"https://seekingalpha.com/news/3369904-premarket-analyst-action-healthcare\" target=\"_blank\">action</a>.</li><li><a href='https://seekingalpha.com/symbol/GOGO' title='Gogo'>GOGO</a> <font color='green'>+10%</font>&nbsp;on restructuring <a href=\"https://seekingalpha.com/news/3369829-gogo-plus-6_6-percent-restructuring-plan\" target=\"_blank\">plan</a>.</li><li><a href='https://seekingalpha.com/symbol/OBSV' title='ObsEva'>OBSV</a> <font color='green'>+8%</font>&nbsp;as ObsEva's shares to <a href=\"https://seekingalpha.com/pr/17215375-obseva-sa-start-trading-today-six-swiss-exchange\" target=\"_blank\">start trading</a> on SIX Swiss Exchange.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369955\" data-linked=\"Premarket Gainers as of 9:05 am (07/13/2018)\" data-tweet=\"$PIXY $PIXY $ADXS - Premarket Gainers as of 9:05 am (07/13/2018) https://seekingalpha.com/news/3369955-premarket-gainers-of-9-05-07-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3369955-premarket-gainers-of-9-05-07-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369954\" data-ts=\"1531487296\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRC\" target=\"_blank\">FRC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369954-first-republic-up-q2-eps-beats-loan-originations-wealth-management-rev-rise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Republic up as Q2 EPS beats; loan originations, wealth management rev. rise</a></h4><ul><li>First Republic Bank (NYSE:<a href='https://seekingalpha.com/symbol/FRC' title='First Republic Bank'>FRC</a>)<font color='green'> gains 2.4%</font>&nbsp;in premarket trading as Q2 EPS of $1.20 beats by 3 cents, bolstered by strong loan originations and continued expansion of its wealth management business.</li><li>Loan originations, at $9.4B, its best quarter ever, vs $7.3B Y/Y.</li><li>Net interest income rose to $611.7M from $532.0M in Q1and $587.8M a year ago; net interest margin was 2.95% vs. 2.97% in Q1 and 3.16% a year ago.</li><li>Wealth management revenue rises to $104.9M, up 22% Y/Y.</li><li>Investment management fees $82.9M vs $68.8M in Q1 and $78.1M a year ago.</li><li>Total noninterest income $132.4M vs $109.4M in Q1 and $133.1M a year ago.</li><li>Total deposits rise 15% to $72.8B Y/Y.</li><li>Provision for loan losses $19.4M vs. $23.9M in Q1 and $13M a year ago.</li><li>Effective tax rate 16.8% vs. 19.2% in Q1.</li><li>Common equity tier 1 capital to risk-weighted assets 10.18% vs 10.47% at Q1 end and 10.72% at June 30, 2017.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17215479-first-republic-reports-strong-second-quarter-2018-results\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3369923-first-republic-bank-beats-0_03-misses-revenue\" target=\"_blank\">First Republic Bank beats by $0.03, misses on revenue</a> (July 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369954\" data-linked=\"First Republic up as Q2 EPS beats; loan originations, wealth management rev. rise\" data-tweet=\"$FRC - First Republic up as Q2 EPS beats; loan originations, wealth management rev. rise https://seekingalpha.com/news/3369954-first-republic-up-q2-eps-beats-loan-originations-wealth-management-rev-rise?source=tweet\" data-url=\"https://seekingalpha.com/news/3369954-first-republic-up-q2-eps-beats-loan-originations-wealth-management-rev-rise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369949\" data-ts=\"1531486615\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WETF\" target=\"_blank\">WETF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369949-wisdomtree-down-4-two-bulls-bail\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WisdomTree down 4% as two bulls bail</a></h4><ul><li>KBW's Robert Lee last night downgraded WisdomTree (NASDAQ:<a href='https://seekingalpha.com/symbol/WETF' title='WisdomTree Investments, Inc.'>WETF</a>) to Market Perform from Outperform, and trimmed his price target to $10 from $12.50.</li><li>This morning, Citi's William Katz cuts to Neutral from Buy.</li><li>Shares were&nbsp;<font color='red'>down 26%</font>&nbsp;year-to-date, and now&nbsp;<font color='red'>off another 4.25%</font>&nbsp;to $8.80 in premarket action.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369949\" data-linked=\"WisdomTree down 4% as two bulls bail\" data-tweet=\"$WETF - WisdomTree down 4% as two bulls bail https://seekingalpha.com/news/3369949-wisdomtree-down-4-two-bulls-bail?source=tweet\" data-url=\"https://seekingalpha.com/news/3369949-wisdomtree-down-4-two-bulls-bail\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369940\" data-ts=\"1531485839\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OGEN\" target=\"_blank\">OGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369940-oragenics-prices-equity-offering-shares-down-31-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oragenics prices equity offering; shares down 31% premarket</a></h4><ul> <li>Nano cap Oragenics (NYSEMKT:<a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a>) is down&nbsp;<font color='red'>31%</font>&nbsp;premarket on increased volume in response to the <a href=\"https://seekingalpha.com/pr/17215503-oragenics-inc-announces-pricing-12-million-underwritten-public-offering\" target=\"_blank\">pricing </a>of its public offering of Class A and Class B Units at $1.00 per Unit.</li><li>Each Class A Unit consists of one share of common stock and one seven-year warrant to purchase one share of common at $1.00. 2.636M are being offered.</li><li>Each Class B Unit consists of one share of Series D Preferred stock, convertible into common stock at $1.00 per share, and one seven-year warrant to purchase one share of common at $1.00. 9.364M are being offered.</li>               <li>Underwriters over-allotment is an additional 1.8M shares and/or additional warrants to purchase       up to 1.8M shares.</li><li>Closing date is July 17.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3369940\" data-linked=\"Oragenics prices equity offering; shares down 31% premarket\" data-tweet=\"$OGEN - Oragenics prices equity offering; shares down 31% premarket https://seekingalpha.com/news/3369940-oragenics-prices-equity-offering-shares-down-31-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3369940-oragenics-prices-equity-offering-shares-down-31-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369945\" data-ts=\"1531485790\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/C\" target=\"_blank\">C</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369945-citigroup-slips-after-q2-revenue-misses-consumer-institutional-falls-from-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citigroup slips after Q2 revenue misses; consumer, institutional falls from Q1</a></h4><ul><li>Citigroup (NYSE:<a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a>)<font color='red'>&nbsp;dips 1.3%</font>&nbsp;in premarket trading as Q2 consumer banking and institutional clients net income recede from Q1 levels.</li><li>Q2 net income growth was primarily driven by higher revenue and lower effective tax rate; Q2 effective tax rate was 24% vs 32% Y/Y.</li><li>Cost of credit rose 6% to $1.8B Y/Y.</li><li>Global consumer banking net income of $1.28B fell 8% from Q1 and rose 14% from a year ago.</li><li>Institutional clients group net income of $3.23B declined 3% from Q1, but was up 17% vs. Q2 2017; investment banking revenue fell 7% and fixed-income markets revenue fell 6% Y/Y, while treasury &amp; trade solutions revenue rose 11% and corporate lending revenue increased 22%.</li><li>Return on average equity of 9.2% vs 9.7% iat Q1 end and 6.8% Y/Y.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17215458-citigroup-reports-second-quarter-2018-financial-results\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3369918-citigroup-beats-0_07-misses-revenue\" target=\"_blank\">Citigroup beats by $0.07, misses on revenue</a> (July 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369945\" data-linked=\"Citigroup slips after Q2 revenue misses; consumer, institutional falls from Q1\" data-tweet=\"$C - Citigroup slips after Q2 revenue misses; consumer, institutional falls from Q1 https://seekingalpha.com/news/3369945-citigroup-slips-after-q2-revenue-misses-consumer-institutional-falls-from-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3369945-citigroup-slips-after-q2-revenue-misses-consumer-institutional-falls-from-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369943\" data-ts=\"1531485527\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DQ\" target=\"_blank\">DQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369943-daqo-new-energy-cuts-q2-sales-volume-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Daqo New Energy cuts Q2 sales volume guidance</a></h4><ul>     <li>Daqo New Energy (NYSE:<a href='https://seekingalpha.com/symbol/DQ' title='DAQO New Energy Corp.'>DQ</a>) <font color='red'>-1.8%</font> premarket after estimating Q2 polysilicon sales to external customers will total 3,800-3,900 MT, <a href=\"https://seekingalpha.com/pr/17215404-daqo-new-energy-announces-updates-second-quarter-2018-sales-guidance-reiterates-full-year\" target=\"_blank\">sharply lower than previous guidance</a> of 5,300-5,500 MT.</li>     <li>DQ also estimates Q2 wafer sales volume totaled 9.5M-10M pieces, also far below its prior outlook for 15M-20M pieces.</li><li>The company cites China's new solar PV policies issued on May 31, which are expected to  reduce solar installation quotas and feed-in tariffs in China during H2 2018.</li>     <li>DQ produced 5,659 MT of polysilicon during Q2, in line with 5,600-5,800 MT guidance, and reiterates FY 2018 polysilicon production guidance of 22K-23K MT.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369943\" data-linked=\"Daqo New Energy cuts Q2 sales volume guidance\" data-tweet=\"$DQ - Daqo New Energy cuts Q2 sales volume guidance https://seekingalpha.com/news/3369943-daqo-new-energy-cuts-q2-sales-volume-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3369943-daqo-new-energy-cuts-q2-sales-volume-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369939\" data-ts=\"1531485071\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADXS\" target=\"_blank\">ADXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369939-fda-lifts-clinical-hold-on-advaxis-study-of-axalimogene-filolisbac-shares-up-61-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA lifts clinical hold on Advaxis study of axalimogene filolisbac; shares up 61% premarket</a></h4><ul><li>Nano cap Advaxis (NASDAQ:<a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis Inc.'>ADXS</a>) is up&nbsp;<font color='green'>61%</font>&nbsp;premarket on increased volume on the heels of its <a href=\"https://seekingalpha.com/pr/17215483-advaxis-announces-fda-lifts-clinical-hold-phase-1-2-combination-study-axalimogene-filolisbac\" target=\"_blank\">announcement </a>that the FDA has lifted the clinical hold on its Phase 1/2 study of axalimogene filolisbac, in combination with AstraZeneca's IMFINZI (durvalumab), for the treatment of advanced, recurrent or refractory cervical cancer and HPV-associated head and neck cancer.</li><li>The agency<a href=\"https://seekingalpha.com/news/3338493-fda-halts-advaxis-phase-1-2-study-axalimogene-filolisbac-patient-death\" target=\"_blank\"> instituted the hold</a> in March following a report on a patient death that occurred in February due to acute respiratory failure after nine months of treatment. New guidelines for the early detection and treatment of such events have now been implemented.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369939\" data-linked=\"FDA lifts clinical hold on Advaxis study of axalimogene filolisbac; shares up 61% premarket\" data-tweet=\"$ADXS - FDA lifts clinical hold on Advaxis study of axalimogene filolisbac; shares up 61% premarket https://seekingalpha.com/news/3369939-fda-lifts-clinical-hold-on-advaxis-study-of-axalimogene-filolisbac-shares-up-61-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3369939-fda-lifts-clinical-hold-on-advaxis-study-of-axalimogene-filolisbac-shares-up-61-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369936\" data-ts=\"1531485007\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STOR\" target=\"_blank\">STOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369936-store-capital-down-1-after-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Store Capital down 1% after downgrade</a></h4><ul><li>Janney's Robert Stevenson rings the register on Store Capital (NYSE:<a href='https://seekingalpha.com/symbol/STOR' title='STORE Capital'>STOR</a>) after about&nbsp;<font color='green'>more than a 20% run higher&nbsp;</font>over the past year (vs. just a 1.6% gain for the broad REIT index).</li><li>Still a believer in the STOR story, Stevenson doesn't see a lot of near-term upside for the shares.</li><li>He downgrades to Hold from Buy.</li><li>Source: Bloomberg</li><li>Shares&nbsp;<font color='red'>-1%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3369936\" data-linked=\"Store Capital down 1% after downgrade\" data-tweet=\"$STOR - Store Capital down 1% after downgrade https://seekingalpha.com/news/3369936-store-capital-down-1-after-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3369936-store-capital-down-1-after-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369933\" data-ts=\"1531484531\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFC\" target=\"_blank\">WFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369933-wells-fargo-falls-q2-logs-declines-in-mortgage-banking-loans-deposits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo falls as Q2 logs declines in mortgage banking, loans, deposits</a></h4><ul><li>Wells Fargo (NYSE:<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Co.'>WFC</a>) declines 3% in premarket trading as Q2 EPS misses consensus estimate by 4 cents, logging declines in mortgage banking, loans and deposits.</li><li>Q2 net EPS of 98 cents includes net discrete income tax expense of 10 cents a share mostly related to state income taxes driven by the recent U.S. Supreme Court decision regarding Wayfair.</li><li>Excluding the tax item, Q2 EPS would have been $1.08 the same as a year ago.</li><li>Net interest income $12.5B, up 1% Y/Y.</li><li>Mortgage banking income was $770M, down from $934M in Q1.</li><li>Market sensitive revenue was $527M, down from $1.0B in Q1.</li><li>Average loans $944.1B vs. $951B in Q1 and $956.9B a year ago.</li><li>Average deposits of $1.27T vs $1.30B in Q1 and $1.30B&nbsp; a year ago.</li><li>Provision for loan losses of $452M ,&nbsp; down 19% Y/Y with net charge-offs of $602M, down $53M Y/Y. Net charge-offs were 0.26% of average total loans vs. 0.32% for Q1 and 0.27% a year ago.</li><li>Return on equity 12.62% at June 30, 2018, unchanged from Q1 end, vs. 14.41% a year ago.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17215491-wells-fargo-reports-5_2-billion-quarterly-net-income\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3369922-wells-fargo-misses-0_04-misses-revenue\" target=\"_blank\">Wells Fargo misses by $0.04, misses on revenue</a> (July 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369933\" data-linked=\"Wells Fargo falls as Q2 logs declines in mortgage banking, loans, deposits\" data-tweet=\"$WFC - Wells Fargo falls as Q2 logs declines in mortgage banking, loans, deposits https://seekingalpha.com/news/3369933-wells-fargo-falls-q2-logs-declines-in-mortgage-banking-loans-deposits?source=tweet\" data-url=\"https://seekingalpha.com/news/3369933-wells-fargo-falls-q2-logs-declines-in-mortgage-banking-loans-deposits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369931\" data-ts=\"1531483982\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369931-premarket-analyst-action-tech-telecom\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - tech/telecom</a></h4><ul><li>BlackBerry (NYSE:<a href='https://seekingalpha.com/symbol/BB' title='BlackBerry Ltd.'>BB</a>) resumed with Buy rating at Cross Research. Shares down a fraction premarket.</li><li>Broadcom (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a>) downgraded to Market Perform with a $230 (10% upside) price target at BMO. Downgraded to Market Perform at Raymond James. Shares up a fraction premarket.</li><li>AT&amp;T (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) downgraded to Market Perform at Raymond James. Shares down&nbsp;<font color='red'>2%&nbsp;</font>premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369931\" data-linked=\"Premarket analyst action - tech/telecom\" data-tweet=\"$BB $BB $AVGO - Premarket analyst action - tech/telecom https://seekingalpha.com/news/3369931-premarket-analyst-action-tech-telecom?source=tweet\" data-url=\"https://seekingalpha.com/news/3369931-premarket-analyst-action-tech-telecom\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369917\" data-ts=\"1531483112\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PIXY\" target=\"_blank\">PIXY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369917-shiftpixy-soars-after-posting-fq3-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ShiftPixy soars after posting FQ3 update</a></h4><ul> <li>ShiftPixy (NASDAQ:<a href='https://seekingalpha.com/symbol/PIXY' title='ShiftPixy'>PIXY</a>) soars after forecasting revenue rose 103% to $9.4M in FQ3 and posting a narrower loss than a year ago.</li> <li>Shares of the woekplace engagement platform are <font color='green'>up 26.64%</font> in premarket action to $3.47 on trading volume of just over 210K.</li><li>ShiftPixy priced its IPO about 13 months ago at $6.00 per share.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3369821-shiftpixy-6-percent-post-q3-2018-interim-results\" target=\"_blank\">ShiftPixy up ~6% post Q3 2018 interim results</a> (July 12)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3369917\" data-linked=\"ShiftPixy soars after posting FQ3 update\" data-tweet=\"$PIXY - ShiftPixy soars after posting FQ3 update https://seekingalpha.com/news/3369917-shiftpixy-soars-after-posting-fq3-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3369917-shiftpixy-soars-after-posting-fq3-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369912\" data-ts=\"1531482145\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369912-t-bull-pulls-in-reins-after-doj-appeal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AT&amp;T bull pulls in reins after DOJ appeal</a></h4><ul><li>Raymond James analyst Frank Louthan figures the DOJ's appeal of the Time Warner deal is likely to cause a significant overhang an extended period of time.</li><li>While the DOJ's case is \"absurd,\" that doesn't prevent the government bureaucracy from following \"the coyote off a cliff,\" says Louthan, and he expects AT&amp;T (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) to ultimately prevail.</li><li>Shares&nbsp;<font color='red'>down 1.4%&nbsp;</font>premarket</li><li>Previously: <a href=\"https://seekingalpha.com/news/3369814-doj-appealing-and-t-time-warner-merger-approval-updated\" target=\"_blank\">DOJ appealing AT&amp;T/Time Warner merger approval (updated)</a> (July 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369912\" data-linked=\"AT&amp;T bull pulls in reins after DOJ appeal\" data-tweet=\"$T - AT&amp;T bull pulls in reins after DOJ appeal https://seekingalpha.com/news/3369912-t-bull-pulls-in-reins-after-doj-appeal?source=tweet\" data-url=\"https://seekingalpha.com/news/3369912-t-bull-pulls-in-reins-after-doj-appeal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>113&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369910\" data-ts=\"1531482091\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PNC\" target=\"_blank\">PNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369910-pnc-financial-up-q2-margin-expands-on-higher-fee-income-net-interest-income\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PNC Financial up as Q2 margin expands on higher fee income, net interest income</a></h4><ul><li>PNC Financial (NYSE:<a href='https://seekingalpha.com/symbol/PNC' title='PNC Financial Services Group, Inc.'>PNC</a>)&nbsp;<font color='green'>up 2.2%</font>&nbsp;in premarket trading as Q2 margin expands on higher fee income and net interest income, while managing expenses.</li><li>Q2 net interest income up by 2% to $2.4B vs. Q1 on higher loan and securities yields and additional day in Q2 partly offset by increased funding costs.</li><li>Net interest margin increased to 2.96% vs. 2.91% in Q1 and 2.84% a year ago.</li><li>Noninterest income rose $161M from Q1 due to strong fee income growth and higher other noninterest income; consumer service fees grew by $24M and corporate service fees increased $58M; residential mortgage revenue decreased $13M.</li><li>Average loans increased 1% to $1.6B vs Q1.</li><li>Net charge-offs declined to $109M vs $113M in Q1.</li><li>Average balances held with the Federal Reserve declined by $4.7B to $20.7B in Q2 compared with Q1.</li><li>Return on average common equity of 12.13% vs 11.04% at Q1 end and 9.88% a year ago.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17215429-pnc-reports-second-quarter-2018-net-income-1_4-billion-2_72-diluted-eps\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3369890-pnc-financial-beats-0_14-beats-revenue\" target=\"_blank\">PNC Financial beats by $0.14, beats on revenue</a> (July 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369910\" data-linked=\"PNC Financial up as Q2 margin expands on higher fee income, net interest income\" data-tweet=\"$PNC - PNC Financial up as Q2 margin expands on higher fee income, net interest income https://seekingalpha.com/news/3369910-pnc-financial-up-q2-margin-expands-on-higher-fee-income-net-interest-income?source=tweet\" data-url=\"https://seekingalpha.com/news/3369910-pnc-financial-up-q2-margin-expands-on-higher-fee-income-net-interest-income\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369909\" data-ts=\"1531481991\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369909-johnson-johnson-down-2-premarket-on-4_69b-talcum-powder-award\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Johnson &amp; Johnson down 2% premarket on $4.69B talcum powder award</a></h4><ul><li>Johnson &amp; Johnson (NYSE:<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a>) slips&nbsp;<font color='red'>2%</font>&nbsp;premarket on light volume on the heels of a <a href=\"https://seekingalpha.com/news/3369855-j-and-j-slammed-4_69b-jury-verdict-missouri-cancer-case\" target=\"_blank\">$4.69B award</a> from a Missouri jury in talcum powder case. The company will most certainly appeal the decision and has been successful in doing so.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3274687-talc-lawsuit-mistrial-j-and-j\" target=\"_blank\">Talc lawsuit mistrial for J&amp;J</a> (June 21, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369909\" data-linked=\"Johnson &amp; Johnson down 2% premarket on $4.69B talcum powder award\" data-tweet=\"$JNJ - Johnson &amp; Johnson down 2% premarket on $4.69B talcum powder award https://seekingalpha.com/news/3369909-johnson-johnson-down-2-premarket-on-4_69b-talcum-powder-award?source=tweet\" data-url=\"https://seekingalpha.com/news/3369909-johnson-johnson-down-2-premarket-on-4_69b-talcum-powder-award\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369904\" data-ts=\"1531481454\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACRX\" target=\"_blank\">ACRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369904-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>AcelRx Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a>) initiated with Market Perform rating at Oppenheimer.</li><li>ADMA Biologics (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMA' title='ADMA Biologics Inc'>ADMA</a>) resumed with Outperform rating and $13 (187% upside) price target at Oppenheimer.</li><li>Avenue Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ATXI' title='Avenue Therapeutics'>ATXI</a>) initiated with Outperform rating and $8 (117% upside) price target at Oppenheimer.</li><li>Catalyst Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a>) initiated with Outperform rating and $6 (88% upside) price target at Oppenheimer.</li><li>Galmed Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a>) initiated with Buy rating and $35 (174% upside) price target at Stifel. Shares up&nbsp;<font color='green'>8%&nbsp;</font>premarket.</li><li>InflaRx N.V. (NASDAQ:<a href='https://seekingalpha.com/symbol/IFRX' title='InflaRx N.V.'>IFRX</a>) initiated with Outperform rating and $45 (48% upside) price target at BMO.</li><li>MEI Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/MEIP' title='MEI Pharma, Inc.'>MEIP</a>) initiated with Buy rating and $12 (157% upside) price target at SunTrust.</li><li>Verastem (NASDAQ:<a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a>) initiated with Buy rating and $17 (113% upside) price target at BTIG Research. Shares up&nbsp;<font color='green'>3%</font>&nbsp;premarket.</li><li>Incyte (NASDAQ:<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a>) downgraded to Equal Weight with a $76 (7% upside) price target at Morgan Stanley. Shares down&nbsp;<font color='red'>2%</font>&nbsp;premarket.</li><li>Acceleron Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/XLRN' title='Acceleron Pharma Inc.'>XLRN</a>) downgraded to Equal Weight with a $50 (6% upside) price target at Morgan Stanley.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369904\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$ACRX $ACRX $ADMA - Premarket analyst action - healthcare https://seekingalpha.com/news/3369904-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3369904-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369899\" data-ts=\"1531480606\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GIS\" target=\"_blank\">GIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369899-susquehanna-positive-on-general-mills\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Susquehanna positive on General Mills</a></h4><ul> <li>Susquehanna analyst Pablo Zuanic posts an assessment on General Mills (NYSE:<a href='https://seekingalpha.com/symbol/GIS' title='General Mills, Inc.'>GIS</a>) following the company's investor day event.</li> <li>\"We see the Blue Buffalo integration, improving underlying trends in the US retail unit, and profit margin stabilization, as key drivers for the stock,\" writes Zuanic.</li> <li>\"Clearly, sector wise, as pricing has started to kick in (or companies show great conviction of improving price/mix trends), consumer staples stocks are now performing better. We expect this to continue, and while the tide will help rise all boats, we prefer GIS (and SJM) in large cap food on valuation and catalysts,\" he adds.</li> <li>Susquehanna keeps a Positive rating on GIS and price target of $54.</li> <li>General Mills <font color='green'>+1.12%</font> in premarket trading to $45.08 vs. a 52-week trading range of $41.01 to $60.69.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3369899\" data-linked=\"Susquehanna positive on General Mills\" data-tweet=\"$GIS - Susquehanna positive on General Mills https://seekingalpha.com/news/3369899-susquehanna-positive-on-general-mills?source=tweet\" data-url=\"https://seekingalpha.com/news/3369899-susquehanna-positive-on-general-mills\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369889\" data-ts=\"1531479203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JPM\" target=\"_blank\">JPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369889-jpmorgan-chase-beats-0_07-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan Chase beats by $0.07, beats on revenue</a></h4><ul><li>JPMorgan Chase (NYSE:<a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a>): Q2 EPS of $2.29 <font color='green'>beats by $0.07</font>.</li><li>Revenue of $28.39B (+10.2% Y/Y) <font color='green'>beats by $1.1B</font>.</li><li>Shares <font color='green'>+1.26%</font> PM.</li><li><a href='https://seekingalpha.com/pr/17215425-jpmorgan-chase-reports-second-quarter-2018-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3369889\" data-linked=\"JPMorgan Chase beats by $0.07, beats on revenue\" data-tweet=\"$JPM - JPMorgan Chase beats by $0.07, beats on revenue https://seekingalpha.com/news/3369889-jpmorgan-chase-beats-0_07-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3369889-jpmorgan-chase-beats-0_07-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":57,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}